⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PGEN News
Precigen, Inc. Common Stock
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
prnewswire.com
PGEN
Form 8-K
sec.gov
PGEN
Precigen Reports First Quarter 2026 Financial Results and Business Updates
prnewswire.com
PGEN
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
accessnewswire.com
PGEN
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
prnewswire.com
PGEN
Form 8-K
sec.gov
PGEN
Precigen Reports Full Year 2025 Financial Results and Business Updates
prnewswire.com
PGEN
ProgenyHealth Releases 2026 Maternal & Infant Health Trends Report
prnewswire.com
PGEN
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
prnewswire.com
PGEN
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
PGEN